Translational Repression in Malaria Sporozoites

被引:8
作者
Turque, Oliver [1 ]
Tsao, Tiffany [1 ]
Li, Thomas [1 ]
Zhang, Min [1 ,2 ]
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, HIV & Malaria Vaccine Program, 1230 York Ave, New York, NY 10021 USA
[2] NYU, Sch Med, Dept Pathol, New York, NY USA
来源
MICROBIAL CELL | 2016年 / 3卷 / 05期
基金
巴西圣保罗研究基金会; 美国国家卫生研究院;
关键词
Plasmodium; sporozoites; latency; eIF2; alpha; UIS1; UIS2; translational repression;
D O I
10.15698/mic2016.05.502
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Malaria is a mosquito-borne infectious disease of humans and other animals. It is caused by the parasitic protozoan, Plasmodium. Sporozoites, the infectious form of malaria parasites, are quiescent when they remain in the salivary glands of the Anopheles mosquito until transmission into a mammalian host. Metamorphosis of the dormant sporozoite to its active form in the liver stage requires transcriptional and translational regulations. Here, we summarize recent advances in the translational repression of gene expression in the malaria sporozoite. In sporozoites, many mRNAs that are required for liver stage development are translationally repressed. Phosphorylation of eukaryotic Initiation Factor 2 alpha (eIF2 alpha) leads to a global translational repression in sporozoites. The eIF2 alpha kinase, known as Upregulated in Infectious Sporozoite 1 (UIS1), is dominant in the sporozoite. The eIF2 alpha phosphatase, UIS2, is translationally repressed by the Pumilio protein Puf2. This translational repression is alleviated when sporozoites are delivered into the mammalian host.
引用
收藏
页码:227 / 229
页数:3
相关论文
empty
未找到相关数据